"Effect of kushthadi churna and its ointment in the management of eczema" eczema"

"Pharmaceutico-clinical study of Kushthadi Churna and its ointment and their efficacy in the management of Vicharchika"

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040618

Enrollment

Registered

2022-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Kushthadi Churna Ointment: Patient will be given local application of Kushthadi Churna Ointment (Quantity Sufficient 2-3 times/day) with starch tablet 500mg BD with water for 28 days f

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having classical clinical features of Vicharhcika a. Kandu b. Pidika c. Shyavavarnata d. Bahusravah/Rukshtaka e. Raga f. Daha 2 Duration of the disease: Chronicity for less than 2 years, recurrent in nature and or not responding to conventional therapy. 3 Mild to moderate cases of eczema as per EASI.

Exclusion criteria

Exclusion criteria: 1 Age below 30 years and above 60 years. 2 Severe cases of eczema as per EASI. 3 Patients under long standing medication, suffering from systemic or linked disease. 4 Pregnant and lactating women. 5 Chronicity more than 2 years. 6 Patients with acute and chronic systemic and metabolic disorders.

Design outcomes

Primary

Measure	Time frame
SOP and efficacy of Kushthadi Churna and its ointment would be established.Timepoint: 28 days	—

Secondary

Measure	Time frame
This study will provide the analytical profile and shelf life of Kushthadi Churna ointmentTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Pramod R Yadav

All India Institute of Ayurveda

drpramod88@gmail.com8930625596

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026